Whitehawk Therapeutics, Inc.
WHWK
$1.65
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -9.33% | 16.51% | 6.69% | 7.80% | 10.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -9.33% | 16.51% | 6.69% | 7.80% | 10.57% |
| Cost of Revenue | 54.96% | -9.43% | 4.48% | 10.45% | 22.48% |
| Gross Profit | -105.03% | 29.60% | -2.51% | -12.97% | -33.70% |
| SG&A Expenses | -7.70% | -11.41% | -17.51% | -20.45% | -8.92% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.38% | -10.32% | -5.70% | -4.62% | 6.85% |
| Operating Income | -41.09% | 18.89% | 9.89% | 8.76% | -5.65% |
| Income Before Tax | 84.08% | 140.12% | 3.15% | 2.73% | -6.26% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 84.08% | 140.12% | 3.15% | 2.72% | -6.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 84.08% | 140.12% | 3.15% | 2.72% | -6.27% |
| EBIT | -41.09% | 18.89% | 9.89% | 8.76% | -5.65% |
| EBITDA | -41.22% | 18.96% | 9.95% | 8.81% | -5.59% |
| EPS Basic | 97.60% | 106.40% | 3.57% | 3.12% | 0.33% |
| Normalized Basic EPS | 10.70% | 23.88% | 7.57% | 7.27% | 0.35% |
| EPS Diluted | 97.11% | 105.92% | 3.48% | 3.03% | 0.24% |
| Normalized Diluted EPS | 10.81% | 23.99% | 7.57% | 7.27% | 0.35% |
| Average Basic Shares Outstanding | 50.92% | 12.07% | 0.43% | 0.44% | 5.94% |
| Average Diluted Shares Outstanding | 51.19% | 12.34% | 0.43% | 0.44% | 5.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |